ArticleScientific reports2025
National trends in stroke hospitalisations, mortality, and recurrent stroke in Australia and New Zealand.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Robust data on trends in stroke hospitalisation rate and outcomes are needed to improve stroke care, yet are sparse and show conflicting results. We investigated the trends in hospitalisation rate, survival, and risk of stroke recurrence following an acute stroke using population-wide data from Australia and New Zealand over a 10-year period. We included adults aged ≥ 18 years hospitalised with an acute stroke from 2008 to 17. Age- and sex-standardized trends of stroke hospitalisation were calculated. Flexible parametric survival models were used to estimate and assess trends in survival and cumulative incidence of stroke recurrence at 30 days, 1 year and 5 years. 331,016 patients were included (mean age 73.2 ± 14.5 years, 48.0% female), with ischaemic stroke (185,800, 56.1%) being the most common type, followed by haemorrhagic stroke (81,877, 24.7%) and unspecified stroke (63,339, 19.1%). The overall age- and sex-standardised stroke hospitalisation rate decreased by 13.5% (179.3/100,000 person-years in 2008 to 155.1/100,000 person-years in 2017, P for trend < 0.01). However, the decline was limited to those ≥ 65 years, with the hospitalisation rate rising in those aged 55-64 years and stagnant in those aged 18-54 years. The adjusted survival probability at 30-day (83.4% in 2008/2009 to 85.9% in 2016/2017), 1-year (70.5% to 74.3%), and 5-year (51.4% to 53.0%) following a stroke has improved over time (P for trend < 0.01). The adjusted risk of stroke recurrence at 30 days and 5 years was unchanged over time, whereas the 1-year risk increased from 9.8% in 2008-2009 to 10.8% in 2016 (P for trend < 0.01). In patients hospitalised for acute stroke in Australia and New Zealand, the overall stroke hospitalisation rate and mortality declined over 10 years. However, this was accompanied by a static or rising stroke hospitalisation rate in younger patients and a concerning lack of improvement in the risk of stroke recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.